JPMorgan Chase & Co’s Clover Health Investments CLOV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.77M | Buy |
633,700
+186,047
| +42% | +$519K | ﹤0.01% | 3413 |
|
|
2025
Q1 | $1.61M | Buy |
447,653
+15,385
| +4% | +$55.2K | ﹤0.01% | 3390 |
|
|
2024
Q4 | $1.36M | Buy |
432,268
+273,348
| +172% | +$861K | ﹤0.01% | 3611 |
|
|
2024
Q3 | $448K | Buy |
+158,920
| New | +$448K | ﹤0.01% | 4076 |
|
|
2024
Q2 | – | Sell |
-868,542
| Closed | -$690K | – | 6331 |
|
|
2024
Q1 | $690K | Buy |
868,542
+741,421
| +583% | +$589K | ﹤0.01% | 3779 |
|
|
2023
Q4 | $121K | Buy |
127,121
+125,400
| +7,286% | +$119K | ﹤0.01% | 4687 |
|
|
2023
Q3 | $1.86K | Hold |
1,721
| – | – | ﹤0.01% | 5605 |
|
|
2023
Q2 | $1.54K | Sell |
1,721
-460,156
| -100% | -$413K | ﹤0.01% | 5478 |
|
|
2023
Q1 | $390K | Buy |
461,877
+92,006
| +25% | +$77.7K | ﹤0.01% | 3955 |
|
|
2022
Q4 | $344K | Buy |
369,871
+35,233
| +11% | +$32.8K | ﹤0.01% | 3945 |
|
|
2022
Q3 | $569K | Buy |
334,638
+11,882
| +4% | +$20.2K | ﹤0.01% | 3663 |
|
|
2022
Q2 | $691K | Buy |
322,756
+245,037
| +315% | +$525K | ﹤0.01% | 3698 |
|
|
2022
Q1 | $276K | Buy |
77,719
+7,199
| +10% | +$25.6K | ﹤0.01% | 4276 |
|
|
2021
Q4 | $262K | Sell |
70,520
-65,535
| -48% | -$243K | ﹤0.01% | 4394 |
|
|
2021
Q3 | $1.01M | Buy |
136,055
+110,072
| +424% | +$813K | ﹤0.01% | 3603 |
|
|
2021
Q2 | $346K | Buy |
+25,983
| New | +$346K | ﹤0.01% | 4202 |
|
|
2021
Q1 | – | Sell |
-2,522
| Closed | -$42K | – | 5257 |
|
|
2020
Q4 | $42K | Buy |
+2,522
| New | +$42K | ﹤0.01% | 4482 |
|